NCT05496582Recruiting
The Association of Transgelin-2, Metallothionein-2 and Ezrin With Asthma
The Association of Transgelin-2, Metallothionein-2 and Ezrin With Asthma: A Case-control Study
Source: ClinicalTrials.gov · Last updated 8 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Asthma is one of the most common chronic respiratory diseases. Previous study found a series of differentially expressed genes and proteins (transgelin-2, metallothionein-2, ezrin) in asthmatic rat. The aim of the study is to investigate the changes and associations of these gene with asthma in human.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 9 Aug 2022
- Start date
- 1 Nov 2022
- Primary completion date
- Aug 2026
- Lead sponsor
- Shanghai University of Traditional Chinese Medicine
- Diseases
- Asthma
- NCT number
- NCT05496582
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Nov 2022 to the primary completion date, Aug 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with chronic obstructive pulmonary disease or other airway disease;
- Complicated with other severe primary diseases (including hypertension, cancer, hyperthyroidism, bronchiectasia, cardiac insufficiency) and conditions that would prevent participation in the trial or put the participant at risk;
- Psychiatric history and neurological disorders can not work normally;
- Other conditions that the researcher considers inappropriate to participate in this study.
Other
- Women who are known to be pregnant or breastfeeding;
- Not willing to participate;
Who the study is looking for
- Males or females, aged 14-75 years;
- Patients with a definite diagnosis of bronchial asthma;
- The diagnosis of asthma according to the Global Initiative for Asthma (GINA), with positive bronchodilator responsiveness (reversibility) test;
- Healthy volunteers without respiratory symptoms such as cough, wheezing, chest tightness or dyspnea;
- Agree with all procedures in this trial by signing a written informed consent form.
Age in the registry: 14 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xiangya Hospital Central South University Coordinator of this site? Confirm its status | Changsha | China | Recruiting |
| Yueyang Hospital, Shanghai University of Traditional Chinese Medicine Coordinator of this site? Confirm its status | Shanghai | China | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.